Cardiac Leads Market Size, Share and Trends Analysis | Global | 2022-2028 | MedCore | Includes: Leads, Pacing Leads, and 2 more

The global cardiac leads market is valued at $1.4 billion in 2021 and is projected to grow at a CAGR of 2.3% to reach $1.7 billion in the forecast period. Our comprehensive market research analyzed companies producing cardiac leads across over 70 countries, to determine market sizes, unit sales, company market shares and generate precise forecasts.

Our full report suite on the global cardiac leads market encompasses all types of cardiac leads including pacing leads, defibrillation leads and left ventricle (LV) leads.

MARKET REPORT DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2028, and Historical Data to 2018
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

GLOBAL CARDIAC LEADS MARKET TRENDS

The increasing age of the population and the rising rates of obesity are driving factors for the growth of the cardiac leads market. As cardiovascular disease becomes more prevalent among patients over 55 years of age, the demand for pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices is expected to increase. This, in turn, will drive the demand for cardiac leads, as they are a crucial component of these medical devices. The growing use of these devices, coupled with an aging population, will contribute to the continued growth of the cardiac leads market.

GLOBAL CARDIAC LEADS MARKET SHARE INSIGHTS

The global cardiac leads market is dominated by three major players - Medtronic, Abbott, and Boston Scientific. In 2021, Medtronic was the market leader. The company offers a comprehensive range of devices, including the Sprint Quattro®, CapSure™ pacing leads, and Attain™ LV leads. These products are highly sought after by healthcare providers and patients alike, due to their quality and effectiveness. With its strong market position, Medtronic is well positioned to continue to lead the cardiac leads market in the coming years.

GLOBAL CARDIAC LEADS MARKET SEGMENTATION SUMMARY

• Cardiac Leads
• Pacing Leads
• Defibrillation Leads
• Left ventricle (LV) leads

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2021
• Forecast: 2022-2028
• Historical Data: 2018-2021

• Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

• Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Databas

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.